Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort studyCarlotta Becherini, Eva Blondeaux, Virginia Delucchi, et al.The Lancet. Oncology|May 10, 2025
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort studyEva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, et al.Cancer Treatment Reviews|October 22, 2024
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus projectStefania Gori, Fiorenza De Rose, Antonella Ferro, et al.JAMA|December 7, 2023
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort StudyMatteo Lambertini, Eva Blondeaux, Elisa Agostinetto, et al.Cancers|January 30, 2020
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer CasesGisella Figlioli, Anders Kvist, Emma Tham, et al.Breast (Edinburgh, Scotland)|May 27, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitorsRoberta Scafetta, Marco Donato, Carla Gullotta, et al.The Oncologist|April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone MetastasesRoberta Scafetta, Marco Donato, Carla Gullotta, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian studyRoberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk ScoresJulie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, et al.Pageof 12